Progress towards an AIDS mucosal vaccine: an overview (Q36891341)

16 August 2017

1 reference

title

Progress towards an AIDS mucosal vaccine: an overview (English)

1 reference

16 August 2017

Yoshikazu Yuki

1

1 reference

PubMed ID

17652028

16 August 2017

Tomonori Nochi

series ordinal

2

1 reference

PubMed ID

17652028

16 August 2017

Hiroshi Kiyono

series ordinal

3

1 reference

16 August 2017

24 July 2007

1 reference

16 August 2017

1 reference

16 August 2017

87 Suppl 1

1 reference

16 August 2017

S35-44

1 reference

A review of vaccine research and development: the human immunodeficiency virus (HIV).

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

AIDS. Resource needs for HIV/AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Progress and obstacles in the development of an AIDS vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Mucosal vaccines: the promise and the challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Inhibiting sexual transmission of HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Microbicides: a new frontier in HIV prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Interactions of viruses and microparticles with apical plasma membranes of M cells: implications for human immunodeficiency virus transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Transepithelial transport of HIV-1 by M cells is receptor-mediated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

The Role of Mucosal Immunity in Prevention of HIV Transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Genotypic and phenotypic characterization of HIV-1 patients with primary infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Transmission, acute HIV-1 infection and the quest for strategies to prevent infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4+ T Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Perils at mucosal front lines for HIV and SIV and their hosts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

New generation of mucosal adjuvants for the induction of protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

A marvel of mucosal T cells and secretory antibodies for the creation of first lines of defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

NALT- versus Peyer's-patch-mediated mucosal immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Lymphoglandular complexes of the colon: structure and distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Collaboration of epithelial cells with organized mucosal lymphoid tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Intestinal villous M cells: an antigen entry site in the mucosal epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Migration of dendritic cells into lymphatics-the Langerhans cell example: routes, regulation, and relevance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Mucosal immunity and vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Local and systemic immune responses to rectal administration of recombinant cholera toxin B subunit in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Comparison of different routes of vaccination for eliciting antibody responses in the human stomach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Recombinant poxviruses as mucosal vaccine vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guérin vector candidate vaccine for human immunodeficiency virus type 1 in small animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

HIV mucosal vaccine: nasal immunization with rBCG-V3J1 induces a long term V3J1 peptide-specific neutralizing immunity in Th1- and Th2-deficient conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Virus-like particles as HIV-1 vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Mucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Development of a novel fusogenic viral liposome system (HVJ-liposomes) and its applications to the treatment of acquired diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

HIV-1 gp41 envelope residues 650-685 exposed on native virus act as a lectin to bind epithelial cell galactosyl ceramide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

A novel adjuvant for mucosal immunity to HIV-1 gp120 in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

M Cell DNA Vaccination for CTL Immunity to HIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

Mucosal immunity and vaccination against HIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.05.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TUBE.2007.05.005

1 reference

16 August 2017

1 reference

PubMed ID

17652028